Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-11 Sale | 2024-09-13 6:26 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 909 | $11.64 | $10,580 | 17,861 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-12 9:48 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 21,029 | $0.6698 | $14,085 | 260,165 (Indirect Direct) | View |
| 2023-09-11 Sale | 2023-09-13 4:24 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 18,469 | $0.948 | $17,509 | 277,194 (Indirect Direct) | View |
| 2023-08-14 Purchase | 2023-08-14 7:40 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 10,000 | $0.97 | $9,700 | 295,663 (Indirect Direct) | View |
| 2023-03-13 Sale | 2023-03-13 9:21 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 7,562 | $1.53 | $11,570 | 191,663 (Indirect Direct) | View |
| 2023-01-12 Sale | 2023-01-27 4:33 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 11,814 | $1.2 | $14,177 | 199,225 (Indirect Direct) | View |
| 2022-09-12 Sale | 2022-09-13 6:48 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 18,159 | $0.6849 | $12,437 | 207,039 (Indirect Direct) | View |
| 2022-01-05 Sale | 2022-01-07 8:20 pm | Cidara Therapeutics Inc. | CDTX | Tari Leslie Chief Scientific Officer | 1,252 | $1.25 | $1,565 | 170,272 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Option Award | 2024-10-02 5:27 pm | N/A 2034-09-29 | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 150,224 | $0 | 150,224 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-20 6:47 pm | N/A 2034-03-14 | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 333,750 | $0 | 593,915 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 5:26 pm | N/A 2033-03-26 | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 270,000 | $0 | 461,663 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:07 pm | N/A 2032-03-30 | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 157,500 | $0 | 326,198 (Direct) | View |
| 2021-12-29 Exercise | 2022-01-07 8:20 pm | N/A 2027-09-17 | Cidara Therapeutics Inc. | CDTX | Tari Leslie Chief Scientific Officer | 2,101 | $0 | 170,272 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 9:23 pm | N/A N/A | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 148,000 | $0 | 163,849 (Direct) | View |
| 2021-07-30 Option Award | 2021-07-30 8:03 pm | N/A 2031-07-29 | Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2021-07-06 4:29 pm | N/A N/A | Cidara Therapeutics Inc. | CDTX | Tari Leslie Chief Scientific Officer | 0 | $0 | 389,662 (Direct) | View |